Literature DB >> 29107845

Early Alzheimer-type lesions in cognitively normal subjects.

Stergios Tsartsalis1, Aikaterini Xekardaki2, Patrick R Hof3, Enikö Kövari2, Constantin Bouras2.   

Abstract

Amyloid deposits and tau-immunoreactive neurofibrillary tangles, together with neuronal and synaptic loss, are the neuropathological hallmarks of Alzheimer's disease (AD). Both proteins are present in the normal brain during aging. However, the temporal sequence of their involvement in the onset of AD pathology remains controversial. To define whether amyloid β protein deposits or tau protein lesions appear first during normal brain aging, we performed an immunohistological study on serial sections from 105 autopsy brains (age range: 40-104 years) from patients free of clinical signs of cognitive decline, using anti-tau (AT8) and anti-amyloid (4G8) antibodies in the hippocampus, entorhinal cortex, inferior temporal cortex (Brodmann area 20), prefrontal cortex (Brodmann area 9), occipital cortex (Brodmann areas 17 and 18), and in the brainstem. All cases older than 48 years displayed at least a few neurofibrillary tangles, which appeared more frequently in the entorhinal than in the transentorhinal cortex. Tau pathology in these areas preceded tau inclusions in the brainstem. Furthermore, the first site of the apparition of tau pathology is inconsistent, being the entorhinal cortex in most cases, and in fewer cases, the transentorhinal region. There was no case presenting with amyloid deposition in the absence of neurofibrillary tangles, lending evidence to the fact that neurofibrillary tangles appear earlier than amyloid plaques during normal brain aging. However, the role of amyloid in promoting tau deposition cannot be excluded in some cases but may not represent the sole mechanism of disease induction and progression.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid; Brain aging; Neurofibrillary tangle; Primary age-related tauopathy

Mesh:

Substances:

Year:  2017        PMID: 29107845      PMCID: PMC5743763          DOI: 10.1016/j.neurobiolaging.2017.10.002

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  65 in total

1.  The pathological process underlying Alzheimer's disease in individuals under thirty.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2010-12-15       Impact factor: 17.088

Review 2.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes.

Authors:  Iryna Benilova; Eric Karran; Bart De Strooper
Journal:  Nat Neurosci       Date:  2012-01-29       Impact factor: 24.884

3.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.

Authors:  C A Davies; D M Mann; P Q Sumpter; P O Yates
Journal:  J Neurol Sci       Date:  1987-04       Impact factor: 3.181

4.  Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Jennifer L Whitwell; David S Knopman; Mary M Machulda; Stephen D Weigand; Bradley F Boeve; Kejal Kantarci; Leonard Petrucelli; Val J Lowe; Clifford R Jack; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2017-02-03       Impact factor: 17.088

5.  Distinct patterns of neuronal loss and Alzheimer's disease lesion distribution in elderly individuals older than 90 years.

Authors:  P Giannakopoulos; P R Hof; E Kövari; P G Vallet; F R Herrmann; C Bouras
Journal:  J Neuropathol Exp Neurol       Date:  1996-12       Impact factor: 3.685

Review 6.  The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.

Authors:  Johanna L Crimins; Amy Pooler; Manuela Polydoro; Jennifer I Luebke; Tara L Spires-Jones
Journal:  Ageing Res Rev       Date:  2013-03-22       Impact factor: 10.895

7.  Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles.

Authors:  David A Bennett; Philip L De Jager; Sue E Leurgans; Julie A Schneider
Journal:  Neurology       Date:  2009-04-28       Impact factor: 9.910

Review 8.  Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.

Authors:  George S Bloom
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

9.  A 2-process model for neuropathology of Alzheimer's disease.

Authors:  Dan Mungas; Rochelle Tractenberg; Julie A Schneider; Paul K Crane; David A Bennett
Journal:  Neurobiol Aging       Date:  2013-09-27       Impact factor: 4.673

10.  Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid.

Authors:  Michelle E King; Ho-Man Kan; Peter W Baas; Alev Erisir; Charles G Glabe; George S Bloom
Journal:  J Cell Biol       Date:  2006-11-13       Impact factor: 10.539

View more
  15 in total

1.  Primary age-related tauopathy in a Chinese cohort.

Authors:  Xin Wang; Lei Zhang; Hui Lu; Juan-Li Wu; Hua-Zheng Liang; Chong Liu; Qing-Qing Tao; Zhi-Ying Wu; Ke-Qing Zhu
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

Review 2.  Aging: What We Can Learn From Elephants.

Authors:  Daniella E Chusyd; Nicole L Ackermans; Steven N Austad; Patrick R Hof; Michelle M Mielke; Chet C Sherwood; David B Allison
Journal:  Front Aging       Date:  2021-08-26

3.  Evidence of traumatic brain injury in headbutting bovids.

Authors:  Nicole L Ackermans; Merina Varghese; Terrie M Williams; Nicholas Grimaldi; Enna Selmanovic; Akbar Alipour; Priti Balchandani; Joy S Reidenberg; Patrick R Hof
Journal:  Acta Neuropathol       Date:  2022-05-17       Impact factor: 15.887

4.  Cholinergic Hypofunction in Presbycusis-Related Tinnitus With Cognitive Function Impairment: Emerging Hypotheses.

Authors:  Qingwei Ruan; Zhuowei Yu; Weibin Zhang; Jian Ruan; Chunhui Liu; Ruxin Zhang
Journal:  Front Aging Neurosci       Date:  2018-04-06       Impact factor: 5.750

5.  Extracellular Sortilin Proteopathy Relative to β-Amyloid and Tau in Aged and Alzheimer's Disease Human Brains.

Authors:  Tian Tu; Juan Jiang; Qi-Lei Zhang; Lily Wan; Ya-Nan Li; Aihua Pan; Jim Manavis; Xiao-Xin Yan
Journal:  Front Aging Neurosci       Date:  2020-05-12       Impact factor: 5.750

6.  Calpain-mediated tau fragmentation is altered in Alzheimer's disease progression.

Authors:  Hsu-Hsin Chen; Peter Liu; Paul Auger; Seung-Hye Lee; Oskar Adolfsson; Lorianne Rey-Bellet; Julien Lafrance-Vanasse; Brad A Friedman; Maria Pihlgren; Andreas Muhs; Andrea Pfeifer; James Ernst; Gai Ayalon; Kristin R Wildsmith; Thomas G Beach; Marcel P van der Brug
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

Review 7.  A walk through tau therapeutic strategies.

Authors:  Santosh Jadhav; Jesus Avila; Michael Schöll; Gabor G Kovacs; Enikö Kövari; Rostislav Skrabana; Lewis D Evans; Eva Kontsekova; Barbara Malawska; Rohan de Silva; Luc Buee; Norbert Zilka
Journal:  Acta Neuropathol Commun       Date:  2019-02-15       Impact factor: 7.801

8.  Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau.

Authors:  Aysha S Mohamed Lafirdeen; Emmanuel Cognat; Severine Sabia; Claire Hourregue; Matthieu Lilamand; Aline Dugravot; Elodie Bouaziz-Amar; Jean-Louis Laplanche; Jacques Hugon; Archana Singh-Manoux; Claire Paquet; Julien Dumurgier
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

Review 9.  Comparative neuropathology in aging primates: A perspective.

Authors:  Carmen Freire-Cobo; Melissa K Edler; Merina Varghese; Emily Munger; Jessie Laffey; Sophia Raia; Selena S In; Bridget Wicinski; Maria Medalla; Sylvia E Perez; Elliott J Mufson; Joseph M Erwin; Elaine E Guevara; Chet C Sherwood; Jennifer I Luebke; Agnès Lacreuse; Mary A Raghanti; Patrick R Hof
Journal:  Am J Primatol       Date:  2021-07-13       Impact factor: 2.371

10.  Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques.

Authors:  Feng-Qin Zhou; Juan Jiang; Chelsea M Griffith; Peter R Patrylo; Huaibin Cai; Yaping Chu; Xiao-Xin Yan
Journal:  Alzheimers Res Ther       Date:  2018-04-24       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.